Journal of Microbiology

The Microbiological Society of Korea (한국미생물학회)
권호 표지

In situ Delivery of Therapeutic Proteins by Recombinant Lactococcus lactis

  • Published : 2003.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Chronic inflammatory bowel disease (IBD) such as Crohn's disease or ulcerative colitis, affects around 2 in every 1000 individuals in western countries and its incidence, particularly amongst children, is increasing. IBD shows extreme morbidity with impact on all aspects of quality of life. If left untreated, IBD can lead to death. Conventional treatment of IBD involves powerful immunosuppressive chemotherapies and surgical intervention. Long-term anti-inflammatory medication is required and so patients are often subject to a spectrum of unpleasant side effects. Interleukin-10 (IL-10) is a cytokine that acts to suppress inflammation. When however administered by injection, the high levels of IL-10 that are distributed throughout the body also lead to side effects. Lactococcus lactis can be genetically engineered to secrete biologically active cytokines. When applied to the mucosa, these L. lactis can actively deliver such cytokines. By use of this principle we developed a new therapeutic approach for IBD. Administration of L. lactis that secretes murine IL-10 cures and prevents IBD in mice. The use of the engineered L. lactis gets around the problem of delivering IL-10, allowing dramatic reduction of the effective dose. A sincere concern exists about the possible dangers of uncontrolled, deliberate release of genetically modified microorganisms, such as could occur following application in healthcare. We engaged in the establishment of adequate means for biological growth control of engineered L. lactis by targeted gene exchange between thyA and hIL-10.

Keywords

References

  1. Annu. Rev. Microbiol. v.52 Thymine metabolism and thymineless death in prokaryotes and eukaryotes Ahmad,S.I.;S.H.Kirk;A.Eisenstark https://doi.org/10.1146/annurev.micro.52.1.591
  2. J. Exp. Med. v.190 An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation Asseman,C.;S.Mauze;M.W.Leach;R.L.Coffman;F.Powrie https://doi.org/10.1084/jem.190.7.995
  3. Gut v.42 Interleukin 10 is a growth factor for a population of regulatory T cells Asseman,C.;F. Powrie https://doi.org/10.1136/gut.42.2.157
  4. Nat. Biotechnol. v.18 Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria Beninati,C.;M.R.Oggioni;M.Boccanera;M.R.Spinosa;T.Maggi;S.Conti;W.Magliani;F.De Bernardis;G.Teti;A.Cassone;G.Pozzi;L.Polonelli https://doi.org/10.1038/80250
  5. Appl. Environ. Microbiol. v.68 Use of the alr gene as a food-grade selection marker in lactic acid bacteria Bron,P.A.;M.G.Benchimol;J.Lambert;E.Palumbo;M.Deghorain;J.Delcour;W.M.De Vos;M.Kleerebezem;P.Hols https://doi.org/10.1128/AEM.68.11.5663-5670.2002
  6. Proc. Natl. Acad. Sci. USA v.40 Studies on unbalanced growth in Escherichia coli Cohen,S.S.;H.D. Barner https://doi.org/10.1073/pnas.40.10.885
  7. Gastroenterology v.106 Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3',5'-cyclic monophosphate induction in intestinal cells Czerucka,D.;I.Roux;P.Rampal
  8. Mol. Microbiol. v.13 Universal barrier to lateral spread of specific genes among microorganisms Diaz,E.;M.Munthali;V.de Lorenzo;K.N.Timmis https://doi.org/10.1111/j.1365-2958.1994.tb00477.x
  9. Eur. J. Immunol. v.26 Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12 Duchmann,R.;E.Schmitt;P.Knolle;K.H.Meyer zum Buschenfelde;M.Neurath https://doi.org/10.1002/eji.1830260432
  10. J. Nutr. v.130 Interactions mediating bacterial translocation in the immature intestine Duffy,L.C.
  11. Gastroenterology v.119 Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group Fedorak,R.N.;A.Gangl;C.O.Elson;P.Rutgeerts;S.Schreiber;G.Wild;S.B.Hanauer;A.Kilian;M.Cohard;A.LeBeaut;B.Feagan https://doi.org/10.1053/gast.2000.20229
  12. Microbiol. Immunol. v.44 Development of a chromosome-plasmid balanced lethal system for Lactobacillus acidophilus with thyA gene as selective marker Fu,X.;J.G.Xu
  13. Int. J. Food Microbiol. v.42 Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children Fukushima,Y.;Y.Kawata;H.Hara;A.Terada;T.Mitsuoka https://doi.org/10.1016/S0168-1605(98)00056-7
  14. J. Immunol. v.157 Disparate CD4+lamina propria(LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5 Fuss,I.J.;M.Neurath;M.Boirivant;J.S.Klein;C.de la Motte;S.A.Strong;C.Fiocchi;W.Strober
  15. Lancet v.339 Inhibition of NO synthesis in septic shock Geroulanos,S.;J.Schilling;M.Cakmakci;H.H.Jung;F.Largiader https://doi.org/10.1016/0140-6736(92)90128-P
  16. Gut v.45 Effect of probiotic therapy on pro-and anti-inflammatory cytokins in pouchitis Helwig,U.;F.Rizzello;A.Venturi
  17. Clin. Exp. Immunol. v.116 Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production Hessle,C.;L.A.Hanson;A.E.Wold https://doi.org/10.1046/j.1365-2249.1999.00885.x
  18. Antonie Van Leeuwenhoek v.82 genetically modified Streptococcus mutans for the prevention of dental caries Hillman,J.D. https://doi.org/10.1023/A:1020695902160
  19. J. Bacteriol. v.179 The alanine recemase gene is essential for growth of Lactobacillus plantarum Hols,P.;C.Defrenne;T.Ferain;S.Derzelle;B.Delplace;J.Delcour
  20. Appl. Environ. Microbiol. v.63 Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection Hudault,S.;V.Lievin;M.F.Bernet-Camard;A.L.Servin
  21. Nature v.411 Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Hugot,J.P.;M.Chamaillard;H.Zouali;S.Lesage;J.P.Cezard;J.Belaiche;S.Almer;C.Tysk;C.A.O'Morain;M.Gassull;V.Binder;Y.Finkel;A.Cortot;R.Modigliani;P.Laurent Puig;C.Gower Rousseau;J.Macry;J.F.Colombel;M.Sahbatou;G.Thomas https://doi.org/10.1038/35079107
  22. Dig. Dis Sci. v.44 Probiotic bacteria stimulate gut epithelial cell proliferation in rat Ichikawa,H.;T.Kuroiwa;A.Inagaki;R.Shineha;T.Nishihira;S.Satomi;T.Sakata https://doi.org/10.1023/A:1026647024077
  23. Microbiol. Rev. v.59 Bacteriocins of gram-positive bacteria Jack,R.W.;J.R.Tagg;B.Ray
  24. System Appl. Microbiol. v.4 Amino acid degradation by a Lactobacillus plantarum strain from fish Jonsson,S.;E.Clausen;J.Raa https://doi.org/10.1016/S0723-2020(83)80043-5
  25. Am. J. Gastroenterol. v.94 Type 1 T-helper cell predominance in granulomas of Crohn's disease Kakazu,T.;J.Hara;T.Matsumoto;S.Nakamura;N.Oshitani;T.Arakawa;A.Kitano;K.Nakatani;F.Kinjo;T.Kuroki https://doi.org/10.1111/j.1572-0241.1999.01220.x
  26. Lancet v.357 Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial Kalliomaki,M.;S.Salminen;H.Arvilommi;P.Kero;P.Koskinen;E.Isolauri https://doi.org/10.1016/S0140-6736(00)04259-8
  27. Biomol. Eng. v.16 Streptavidin-based containment systems for genetically engineered microorganisms Kaplan,D.L.;C.Mello;T.Sano;C.Cantor;C. Smith https://doi.org/10.1016/S1050-3862(99)00040-6
  28. Appl. Environ. Microbiol. v.61 Development and testing of improved suicide functions for biological containment of bacteria Knudsen,S.;P.Saadbye;L.H.Hansen;A.Collier;B.L.Jacobsen;J.Schlundt;O.H. Karlstrom
  29. Clin. Exp. Immunol. v.107 Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice Kojouharoff,G.;W.Hans;F.Obermeier;D.N.Mannel;T.Andus;J.Scholmerich;V.Gross;W.Falk https://doi.org/10.1111/j.1365-2249.1997.291-ce1184.x
  30. Nat. Biotechnol. v.20 In situ delivery of passive immunity by lactobacilli producing single-chain antibodies Kruger,C.;Y.Hu;Q.Pan;H.Marcotte;A.Hultberg;D.Delwar;P.J.van Dalen;P.H.Pouwels;R.J.Leer;C.G.Kelly;C.van Dollenweerd;J.K.Ma;L.Hammarstrom https://doi.org/10.1038/nbt0702-702
  31. Cell v.75 Interleukin-10-deficient mice develop chronic enterocolitis Kuhn,R.;J.Lohler;D.Rennick;K.Rajewsky;W.Muller https://doi.org/10.1016/0092-8674(93)80068-P
  32. Appl. Environ. Microbiol. v.64 Cloning, expression, and chromosomal stabilization of the Propionibacterium shermanii proline iminopeptidase gene (pip) for food-grade application in Lactococcus lactis. Leenhouts,K.;A.Bolhuis;J.Boot;I.Deutz;M.Toonen;G.Venema;J.Kok;A.Ledeboer
  33. Appl. Microbiol. Biotechnol. v.49 Construction of a food-grade multiple-copy integration system for Lactococcus lactis Leenhouts,K.;A.Bolhuis;G.Venema;J.Kok https://doi.org/10.1007/s002530051192
  34. Gut v.47 Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity Lievin,V.;I.Peiffer;S.Hudault;F.Rochat;D.Brassart;J.R.Neeser;A.L.Servin https://doi.org/10.1136/gut.47.5.646
  35. Vaccine v.18 Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains Maassen,C.B.;C.van Holten- Neelen;F.Balk;M.J.den Bak- Glashouwer;R.J.Leer;J.D.Laman;W.J.Boersma;E.Claassen https://doi.org/10.1016/S0264-410X(99)00378-3
  36. FEMS Microbiol. Lett. v.127 Construction of a food-grade host/vector system for Lactococcus lactis based on the lactose operon MacCormick,C.A.;H.G.Griffin;M.J. Gasson https://doi.org/10.1111/j.1574-6968.1995.tb07457.x
  37. Am. J. Physiol. v.276 Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression Mack,D.R.;S.Michail;S.Wei;L.McDougall;M.A.Hollingsworth
  38. Science v.288 A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria Macpherson,A.J.;D.Gatto;E.Sainsbury;G.R.Harriman;H.Hengartner;R.M.Zinkernagel https://doi.org/10.1126/science.288.5474.2222
  39. Ann. Nutr. Metab. v.40 Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG Malin,M.;H.Suomalainen;M.Saxelin;E.Isolauri https://doi.org/10.1159/000177907
  40. Gastroenterology v.111 The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats Mao,Y.;S.Nobaek;B.Kasravi;D.Adawi;U.Stenram;G.Molin;B.Jeppsson https://doi.org/10.1053/gast.1996.v111.pm8690198
  41. Appl. Environ. Microbiol. v.64 Construction of an efficient biologically contained Pseudomonas putida strain and its survival in outdoor assays Molina,L.;C.Ramos;M.C.Ronchel;S.Molin;J.L.Ramos
  42. Annu. Rev. Immunol. v.7 TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties Mosmann,T.R.;R.L.Coffman https://doi.org/10.1146/annurev.iy.07.040189.001045
  43. Science v.289 Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination Neish,A.S.;A.T.Gewirtz;H.Zeng;A.N.Young;M.E.Hobert;V.Karmali;A.S.Rao;J.L.Madara https://doi.org/10.1126/science.289.5484.1560
  44. Clin. Exp. Immunol. v.101 Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR) Niessner,M.;B.A.Volk https://doi.org/10.1111/j.1365-2249.1995.tb03130.x
  45. J. Appl. Microbiol. v.86 New types of antimicrobial compounds produced by Lactobacillus plantarum Niku-Paavola,M.L.;A.Laitila;T.Mattila-Sandholm;A.Haikara https://doi.org/10.1046/j.1365-2672.1999.00632.x
  46. Am. J. Gastroenterol. v.95 Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome Nobaek,S.;M.L.Johansson;G.Molin;S.Ahrne;B.Jeppsson https://doi.org/10.1111/j.1572-0241.2000.02015.x
  47. J. Food. Prot. v.63 Binding of aflatoxin B1 to bifidobacteria in vitro Oatley,J.T.;M.D.Rarick;G.E.Ji;J.E.Linz
  48. Nature v.411 A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Ogura,Y.;D.K.Bonen;N.Inohara;D.L.Nicolae;F.F.Chen;R.Ramos;H.Britton;T.Moran;R.Karaliuskas;R.H.Duerr;J.P.Achkar;S.R.Brant;T.M.Bayless;B.S.Kirschner;S.B.Hanauer;G.Nunez;J.H.Cho https://doi.org/10.1038/35079114
  49. Appl. Environ. Microbiol. v.62 Food-grade cloning and expression system for Lactococcus lactis Platteeuw,C.;I.van Alen- Boerrigter;S.van Schalkwijk;W.M.de Vos
  50. Lancet v.2 The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Roediger,W.E.
  51. Appl. Environ. Microbiol. v.67 Dual system to reinforce biological containment of recombinant bacteria designed for rhizoremediation Ronchel,M.C.;J.L.Ramos https://doi.org/10.1128/AEM.67.6.2649-2656.2001
  52. Carcinogenesis v.19 Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats Rowland,I.R.;C.J.Rumney;J.T.Coutts;L.C.Lievense https://doi.org/10.1093/carcin/19.2.281
  53. Dig. Dis. Sci. v.44 Probiotic preparations dose-dependently increase net production rates of organic acids and decrease that of ammonia by pig cecal bacteria in batch culture Sakata,T.;T.Kojima;M.Fujieda;M.Miyakozawa;M.Takahashi;K. Ushida https://doi.org/10.1023/A:1026624423767
  54. Am. J. Gastroenterol. v.92 Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases Sartor,R.B.
  55. Gastroenterology v.119 Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group Schreiber,S.;R.N.Fedorak;O.H.Nielsen;G.Wild;C.N.Williams;S.Nikolaus;M.Jacyna;B.A.Lashner;A.Gangl;P.Rutgeerts;K.Isaacs;S.J.van Deventer;J.C.Koningsberger;M.Cohard;A.LeBeaut;S.B.Hanauer https://doi.org/10.1053/gast.2000.20196
  56. Gastroenterology v.114 Continuous feeding of Lactobacillus plantarum attenuates established colitis in interleukin-10 deficient mice (abstr) Schultz,M.
  57. Appl. Microbiol. Biotechnol. v.42 Escherichia coli K12 relA strains as safe hosts for expression of recombinant DNA Schweder,T.;K.Hofmann;M.Hecker https://doi.org/10.1007/BF00171951
  58. Appl. Microbiol. Biotechnol. v.38 An expression vector system providing plasmid stability and conditional suicide of plasmid-containing cells Schweder,T.;I.Schmidt;H.Herrmann;P.Neubauer;M.Hecker;K.Hofmann
  59. Appl. Environ. Microbiol. v.66 A food-grade cloning system for industrial strains of Lactococcus lactis Sorensen,K.I.;R.Larsen;A.Kibenich;M.P.Junge;E.Johansen https://doi.org/10.1128/AEM.66.4.1253-1258.2000
  60. Science v.289 Treatment of murine colitis by Lactococcus lactis secreting interleukin-10 Steidler,L.;W.Hans;L.Schotte;S.Neirynck;F.Obermeier;W.Falk;W.Fiers;E.Remaut https://doi.org/10.1126/science.289.5483.1352
  61. Nat. Biotechnol. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10 Steidler,L.;S.Neirynck;N.Huyghebaert;V.Snoeck;A.Vermeire;B.Goddeeris;E.Cox;J.P.Remon;E.Remaut
  62. Infect. Immun. v.66 Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine Steidler,L.;K.Robinson;L.Chamberlain;K.M.Schofield;E.Remaut;R.W.Le Page;J.M.Wells
  63. Appl. Environ. Microbiol. v.61 Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis Steidler,L.;J.M.Wells;A.Raeymaekers;J.Vandekerckhove;W.Fiers;E.Remaut
  64. Gastroenterology v.119 Identification of a novel bacterial sequence associated with Crohn's disease Sutton,C.L.;J.Kim;A.Yamane;H.Dalwadi;B.Wei;C.Landers;S.R.Targan;J.Braun https://doi.org/10.1053/gast.2000.8519
  65. Appl. Microbiol. Biotechnol. v.59 A food-grade cloning vector for lactic acid bacteria based on the nisin immunity gene nisI Takala,T.M.;P.E.Saris https://doi.org/10.1007/s00253-002-1034-4
  66. J. Biotechnol. v.39 Evaluation of the E. coli ribosomal rrnB P1 promoter and phage-derived lysis genes for the use in a biological containment system: a concept study Tedin,K.;A.Witte;G.Reisinger;W.Lubitz;U.Blasi https://doi.org/10.1016/0168-1656(95)00003-9
  67. J. Immunol. v.169 Role of IL-10 for induction of anemia during inflammation Tilg,H.;H.Ulmer;A.Kaser;G.Weiss
  68. Environ. Microbiol. v.2 A gene containment strategy based on a restriction-modification system Torres,B.;S.Jaenecke;K.N.Timmis;J.L.Garcia;E.Diaz https://doi.org/10.1046/j.1462-2920.2000.00138.x
  69. FEMS Immunol. Med. Microbiol. v.26 The effect of probiotic bateria on the adhesion of pathogens to human intestinal mucus Tuomola,E.M.;A.C.Ouwehand;S.J.Salminen https://doi.org/10.1111/j.1574-695X.1999.tb01381.x
  70. Gastroenterology v.113 Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group van Deventer,S.J.;C.O.Elson;R.N.Fedorak https://doi.org/10.1053/gast.1997.v113.pm9247454
  71. Mol. Microbiol. v.8 Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge Wells,J.M.;P.W.Wilson;P.M.Norton;M.J.Gasson;R.W.Le Page https://doi.org/10.1111/j.1365-2958.1993.tb01660.x
  72. Cardiovasc. Res. v.26 Protective and pathological roles of nitric oxide in endotoxin shock Wright,C.E.;D.D.Rees;S.Moncada https://doi.org/10.1093/cvr/26.1.48